These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35475172)

  • 21. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.
    Jacob IB; Gemmiti A; Xiong W; Reynolds E; Nicholas B; Thangamani S; Jia H; Wang G
    Front Immunol; 2024; 15():1370511. PubMed ID: 38596675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression.
    Carossino M; Montanaro P; O'Connell A; Kenney D; Gertje H; Grosz K; Ericsson M; Huber BR; Subramaniam S; Kirkland TA; Walker JR; Francis KP; Klose AD; Paragas N; Kurnick S; Bosmann M; Saeed M; Balasuriya U; Douam F; Crossland N
    bioRxiv; 2021 Sep; ():. PubMed ID: 33469581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
    Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
    Viruses; 2021 May; 13(6):. PubMed ID: 34064066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
    Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
    Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.
    Song IW; Washington M; Leynes C; Hsu J; Rayavara K; Bae Y; Haelterman N; Chen Y; Jiang MM; Drelich A; Tat V; Lanza DG; Lorenzo I; Heaney JD; Tseng CK; Lee B; Marom R
    Mamm Genome; 2024 Jun; 35(2):113-121. PubMed ID: 38488938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection.
    Zhou X; Sun W; Zhang Y; Gu H; Wang R; Xie P; Zhu Y; Qiu M; Ding X; Wang H; Gao Y; Li J
    Front Microbiol; 2023; 14():1175188. PubMed ID: 37350787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection.
    Katzman C; Israely T; Melamed S; Politi B; Sittner A; Yahalom-Ronen Y; Weiss S; Abu Rass R; Zamostiano R; Bacharach E; Ehrlich M; Paran N; Nissim L
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD147 mediates S protein pseudovirus of SARS-CoV-2 infection and its induction of spermatogonia apoptosis.
    Dai P; Ma C; Jiang T; Shi J; Liu S; Zheng M; Zhou Y; Li X; Liu Y; Chen H
    Endocrine; 2024 Sep; 85(3):1435-1445. PubMed ID: 38824220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humanized mice for investigating SARS-CoV-2 lung infection and associated human immune responses.
    Sun R; Zhao Z; Fu C; Wang Y; Guo Z; Zhang C; Liu L; Zhang C; Shu C; He J; Yang YG; Hua S; Gao Y; Hu Z
    Eur J Immunol; 2022 Oct; 52(10):1640-1647. PubMed ID: 35976660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.
    Manangeeswaran M; Ireland DDC; Thacker SG; Lee HN; Kelley-Baker L; Lewkowicz AP; Rothlauf PW; Cornejo Pontelli M; Bloyet LM; Eckhaus MA; Mendoza MI; Whelan S; Verthelyi D
    Front Immunol; 2022; 13():919815. PubMed ID: 35967447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection.
    Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini M
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptation of SARS-CoV-2 to ACE2
    Li K; Verma A; Li P; Ortiz ME; Hawkins GM; Schnicker NJ; Szachowicz PJ; Pezzulo AA; Wohlford-Lenane CL; Kicmal T; Meyerholz DK; Gallagher T; Perlman S; McCray PB
    J Virol; 2024 Jan; 98(1):e0151023. PubMed ID: 38168680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.
    Le Chevalier F; Authié P; Chardenoux S; Bourgine M; Vesin B; Cussigh D; Sassier Y; Fert I; Noirat A; Nemirov K; Anna F; Bérard M; Guinet F; Hardy D; Charneau P; Lemonnier F; Langa-Vives F; Majlessi L
    Microbes Infect; 2023; 25(7):105142. PubMed ID: 37080384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of model-specific histopathology in mouse models of COVID-19.
    Yang S; Cao L; Xu W; Xu T; Zheng B; Ji Y; Huang S; Liu L; Du J; Peng H; Zhang H; Chen J; Ke B; Zheng H; Deng X; Li C; Guo D
    J Med Virol; 2022 Aug; 94(8):3605-3612. PubMed ID: 35355296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of SARS-CoV-2 entry in gingival epithelial cells expressing CD147.
    Bontempo A; Chirino A; Heidari A; Boparai S; Arora S; Ruiz S; Antonson SA; Kawai T; Cayabyab MJ
    Eur J Oral Sci; 2023 Feb; 131(1):e12906. PubMed ID: 36412995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2.
    Yu F; Liu X; Ou H; Li X; Liu R; Lv X; Xiao S; Hu M; Liang T; Chen T; Wei X; Zhang Z; Liu S; Liu H; Zhu Y; Liu G; Tu T; Li P; Zhang H; Pan T; Ma X
    mBio; 2024 Aug; 15(8):e0108824. PubMed ID: 38953634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.